Kevin Goudy, Ph.D., D(ABMLI)

Kevin Goudy, Ph.D

Director, Molecular Diagnostics

Dr. Kevin Goudy joined CSI Laboratories in 2015 as the Director of Molecular Diagnostics. Dr. Goudy has extensive experience in creating next generation molecular and immunology assays. He has also patented several diagnostic methods and approaches including a method for the isolation of circulating tumor cells.

Prior to joining CSI, Dr. Goudy held the position of Laboratory Director, Director of Research and Development at Pharmacogenetic Laboratories Technologies (PGXL) in Louisville, Kentucky where he was instrumental in developing both diagnostic assays for clinical testing and companion diagnostics for therapeutic monitoring. In addition to his commercial laboratory work, Dr. Goudy also served as a Clinical Assistant Professor for the Department of Pathology and Laboratory Medicine at the University of Louisville in Louisville, Kentucky

Dr. Goudy received his Ph.D. in microbiology and immunology from the University of North Carolina in Chapel Hill, North Carolina. He completed a fellowship in clinical immunology at the University of North Carolina and at the San Raffaele Institute in Milan, Italy.

  • Microbiology and Immunology Fellowship at University of North Carolina, Chapel Hill, North Carolina
  • Board Certified in Immunology by the American Board of Medical Laboratory Immunology (ABMLI)
  • Coinventor of a circulating tumor cell isolation method